Health X Platform Ltd
Health X Platform Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
4 of 4 strong
The short version
July monthly revenue stood at INR 150+ crores, indicating strong growth momentum. Health X aims to convert strong revenue growth into sustainable EBITDA and PAT profitability through operating leverage and tighter cost management.
From Health X Platform Ltd's Q1 FY27 earnings-call transcript · updated 26 Aug 2026.
Revenue & Sales Performance
- July monthly revenue stood at INR 150+ crores, indicating strong growth momentum.
- Expansion into new regions including Odisha, Jharkhand, Bihar, Chhattisgarh, Haryana, UP, Rajasthan, and Northeast India; Northeast shows highest growth.
- Target to double market share in West Bengal from current 3-4% to about 7% over next 2-3 years.
- Growing JITO private label sales rapidly (from INR 25 lakhs to INR 79 lakhs recently), expected to significantly contribute to revenue and gross margin expansion.
- RetailerShakti business focusing on increasing wallet share per retailer, aiming to double it through AI-enabled Retail Air platform launching next quarter.
- Ongoing build-out of warehouses in key geographies to support increased capacity and faster delivery.
2 more points from Health X Platform Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Health X Platform Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Health X is focused on owning its entire logistics and fulfillment centers instead of relying on outside warehouses, making it a USP.
- Existing fulfillment center capacity is running at about 90%, with an "existing plus" sideway extension planned to cover 50%-100% more revenue growth, supporting up to INR 3,000 crores revenue.
- Beyond this, massive infrastructure development is planned to build seamless large-scale capabilities.
- New warehouse capabilities are under construction in multiple locations: Noida (completed), West Bengal (partly done), Guwahati (under construction), Udaipur (started), and planned starts in Patna and Lucknow within 2-3 months.
- Capex plans include shifting from rented warehouses to owned facilities, prioritizing Guwahati.
2 more points from Health X Platform Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Health X Platform Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Health X Platform Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Health X Platform Ltd — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Dec 2025 (Q3 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q3 FY26): revenue ₹346 Cr, net profit ₹0 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Health X Platform's management said in earlier quarters
Others in Healthcare Services this season
- Aatmaj Healthcare Ltd (Q1 FY27)
Revenue for Q1 FY 2026-27: ₹8.13 crore . Key investor presentation takeaways from Aatmaj Healthcare Ltd's Q1 FY27 investor presentation — and how it ranks again
- Asarfi Hospital (Q1 FY27)
Q1'FY27 consolidated revenue from operations: ₹47.5 Cr, up 32.8% YoY (vs ₹35.7 Cr in Q1'FY26) . Key investor presentation takeaways from Asarfi Hospital Ltd's Q
- KMC Speciality (Q1 FY27)
Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26. Key concall takeaways from KMC Speciality Hospitals (India) Ltd's Q1…
- 3B Blackbio (Q1 FY27)
Q1 2026-27 revenue from operations: ₹3,205.73 Lakh (including Coris sales of ₹862.83 Lakh) vs ₹1,996.06 Lakh in Q1 2025-26 — YoY growth approx. Key concall…
Arthneeti Pro · Annual
Health X Platform Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Health X Platform Ltd Q1 FY27 results?
July monthly revenue stood at INR 150+ crores, indicating strong growth momentum. Health X aims to convert strong revenue growth into sustainable EBITDA and PAT profitability through operating leverage and tighter cost management.
What is Health X Platform Ltd share price analysis?
Health X Platform Ltd currently shows a strong growth signal based on ranking data. The stock trades at a P/E of 508.6 with a market cap of ₹977 Cr. Investors should review the full earnings analysis for detailed insights.
Is Health X Platform Ltd planning capital expenditure?
Health X is focused on owning its entire logistics and fulfillment centers instead of relying on outside warehouses, making it a USP.
Keep Health X Platform Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.